Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meetings, 55231-55232 [2019-22378]

Download as PDF 55231 Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices official who may be contacted for additional information is Fred Pietrangeli, Director for Office of Debt Management (202) 622–1876. FOR FURTHER INFORMATION CONTACT: Copies of the submissions may be obtained from Spencer W. Clark by emailing PRA@treasury.gov, calling (202) 927–5331, or viewing the entire information collection request at www.reginfo.gov. SUPPLEMENTARY INFORMATION: Dated: October 4, 2019. Fred Pietrangeli, Director for Office of Debt Management. [FR Doc. 2019–22121 Filed 10–11–19; 8:45 am] BILLING CODE 4810–25–M DEPARTMENT OF THE TREASURY Agency Information Collection Activities; Submission for OMB Review; Comment Request; CDFI Program and NACA Program Application Departmental Offices, U.S. Department of the Treasury. AGENCY: ACTION: Notice. The Department of the Treasury will submit the following information collection requests to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The public is invited to submit comments on these requests. SUMMARY: Comments should be received on or before November 14, 2019 to be assured of consideration. DATES: Send comments regarding the burden estimate, or any other aspect of the information collection, including suggestions for reducing the burden, to (1) Office of Information and Regulatory Affairs, Office of Management and Budget, Attention: Desk Officer for Treasury, New Executive Office Building, Room 10235, Washington, DC 20503, or email at OIRA_Submission@ OMB.EOP.gov and (2) Treasury PRA Clearance Officer, 1750 Pennsylvania Ave. NW, Suite 8100, Washington, DC 20220, or email at PRA@treasury.gov. ADDRESSES: Community Development Financial Institutions Fund (CDFIF) Title: CDFI Program and NACA Program Application. OMB Control Number: 1559–0021. Type of Review: Revision of a currently approved collection. Description: Pursuant to the Riegle Community Development Banking and Financial Institutions Act of 1994, as amended (the Act, 12 U.S.C. 4701 et seq.), the Community Development Financial Institutions (CDFI) Program provides financial and technical assistance to selected applicants and Community Development Financial Institutions (CDFIs) in order to enhance their ability to make loans and investments and provide services for the benefit of designated Investment Areas and Targeted Populations. The application questions for the CDFI Fund’s Financial Assistance (FA) and Technical Assistance (TA) programs have been modified to reflect public comments received through the request for public comment as required the Paperwork Reduction Act (PRA). The revised FA application includes the Base-FA application as well as the following applications for awards that are provided as supplemental to the Base-FA award: Persistent Poverty County Financial Assistance (PPC–FA), Healthy Food Financing InitiativeFinancial Assistance (HFFI–FA), and Disability Funds-Financial Assistance (DF–FA). The supplemental applications are only completed if the applicant is requesting those specific funds. The information collected will be used to select awardees, based on a merit-based selection process. The requested information is required by the CDFI Program regulations (12 CFR part 1805) and respective Notice of Funds Availabilities. Form: None. Affected Public: Businesses or other for-profits, Not-for-profit institutions. Estimated Number of Respondents: 500. Frequency of Response: On occasion. Estimated Total Number of Annual Responses: 500. Estimated Time per Response: 100 hours. Estimated Total Annual Burden Hours: 50,000. Authority: 44 U.S.C. 3501 et seq. Dated: October 8, 2019. Spencer W. Clark, Treasury PRA Clearance Officer. [FR Doc. 2019–22379 Filed 10–11–19; 8:45 am] BILLING CODE 4810–70–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meetings The Department of Veterans Affairs (VA) gives notice under Federal Advisory Committee Act that the subcommittees of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board (JBL/CS SMRB) will be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless otherwise listed) at the 20 F Conference Center, 20 F Street NW, Washington, DC 20001 and at the Office of Research and Development, 1100 First Street NE, Washington, DC 20002: khammond on DSKJM1Z7X2PROD with NOTICES Meeting BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D Date(s) Surgery Subcommittee ............................................................................................................................... Pulmonary Medicine Subcommittee ........................................................................................................... Infectious Diseases-B Subcommittee ........................................................................................................ Oncology-A/D Subcommittee ..................................................................................................................... Hematology Subcommittee ........................................................................................................................ Oncology-C Subcommittee ........................................................................................................................ Cellular & Molecular Medicine Subcommittee ........................................................................................... Oncology-B/E Subcommittee ..................................................................................................................... Immunology & Dermatology-A Subcommittee ........................................................................................... Mental Health & Behavioral Sciences-C Subcommittee ............................................................................ Cardiovascular Studies-A Subcommittee ................................................................................................... Endocrinology-A Subcommittee ................................................................................................................. Mental Health & Behavioral Sciences-P .................................................................................................... Neurobiology-C Subcommittee .................................................................................................................. Neurobiology-E Subcommittee ................................................................................................................... VerDate Sep<11>2014 16:25 Oct 11, 2019 Jkt 250001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1 November November November November November November November November November November November November November November November 12, 13, 14, 14, 15, 15, 18, 18, 20, 20, 21, 21, 21, 21, 22, 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 2019. 55232 Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices Meeting BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS BL/CS R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D R&D Endocrinology-B Subcommittee ................................................................................................................. Mental Health & Behavioral Sciences-A Subcommittee ............................................................................ Nephrology Subcommittee ......................................................................................................................... Neurobiology-B Subcommittee ................................................................................................................... Infectious Diseases-A Subcommittee ........................................................................................................ Neurobiology-F Subcommittee ................................................................................................................... Cardiovascular Studies-B Subcommittee ................................................................................................... Gastroenterology Subcommittee ................................................................................................................ Neurobiology-P Subcommittee ................................................................................................................... Neurobiology-A Subcommittee ................................................................................................................... Neurobiology-D Subcommittee .................................................................................................................. Gulf War Research Subcommittee ............................................................................................................ Eligibility Subcommittee ............................................................................................................................. The purpose of the subcommittees is to provide advice on the scientific quality, budget, safety and mission relevance of investigator-initiated research proposals submitted for VA merit review evaluation. Proposals submitted for review include various medical specialties within the general areas of biomedical, behavioral and clinical science research. These subcommittee meetings will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals, which involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended by Public Law 94–409, closing the subcommittee meetings is in accordance with Title 5 U.S.C. 552b(c)(6) and (9)(B). Those who would like to obtain a copy of the minutes from the closed subcommittee meetings and rosters of the subcommittee members should contact Holly Krull, Ph.D., Manager, Merit Review Program (10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 632–8522 or email at holly.krull@va.gov. khammond on DSKJM1Z7X2PROD with NOTICES Date(s) VerDate Sep<11>2014 16:25 Oct 11, 2019 Jkt 250001 Dated: October 8, 2019. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2019–22378 Filed 10–11–19; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Creating Options for Veterans Expedited Recovery (COVER) Commission, Notice of Meeting In accordance with the Federal Advisory Committee Act, the Creating Options for Veterans Expedited Recovery (COVER) Commission gives notice of a meeting to be held on October 24 and 25, 2019, at the VHA National Conference Center, 2011 Crystal Drive, Crystal City, Virginia 22202. The public session on October 24 will begin at 1:00 p.m. and conclude at approximately 5:00 p.m. On October 25, the public session will begin at 8:30 a.m. and conclude at approximately 12:00 p.m. (all times Eastern). The purpose of the COVER Commission is to examine the evidencebased therapy treatment model used by the Department of Veterans Affairs (VA) for treating mental health conditions of Veterans and the potential benefits of incorporating complementary and integrative health approaches as standard practice throughout the Department. Members of the public are invited to attend open sessions in-person or via PO 00000 Frm 00099 Fmt 4703 Sfmt 9990 November 25, 2019. December 3, 2019. December 3, 2019. December 3, 2019. December 4, 2019. December 4, 2019. December 5, 2019. December 5, 2019. December 5, 2019. December 6, 2019. December 6, 2019. December 6, 2019. January 17, 2020. telephone listening line. Only a limited amount of seating will be available, and members of the public will be seated on a first come-first served basis. The listening line number for October 24 is 844–376–0278 access code 771669984#. The listening line number for October 25 is 844–376–0278 access code 623057095#. Listening lines will be activated approximately 10 minutes prior to each day’s sessions. Members of the public utilizing the listening line are asked to confirm their attendance via an email to COVERCommission@va.gov. The videotaping or recording of Commission proceedings is discouraged as it may be disruptive to the Commission’s work. Any member of the public seeking additional information including copies of materials referenced during open sessions should email the Designated Federal Officer for the Commission, Mr. John Goodrich, at COVERCommission@ va.gov. Although there will not be time allotted for members of the public to speak, the COVER Commission will accept written comments which may be sent to the email address noted. In communications with the Commission, the writers must identify themselves and state the organizations, associations, or persons they represent. Dated: October 8, 2019. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2019–22373 Filed 10–11–19; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\15OCN1.SGM 15OCN1

Agencies

[Federal Register Volume 84, Number 199 (Tuesday, October 15, 2019)]
[Notices]
[Pages 55231-55232]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22378]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board, Notice of Meetings

    The Department of Veterans Affairs (VA) gives notice under Federal 
Advisory Committee Act that the subcommittees of the Joint Biomedical 
Laboratory Research and Development and Clinical Science Research and 
Development Services Scientific Merit Review Board (JBL/CS SMRB) will 
be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless 
otherwise listed) at the 20 F Conference Center, 20 F Street NW, 
Washington, DC 20001 and at the Office of Research and Development, 
1100 First Street NE, Washington, DC 20002:

----------------------------------------------------------------------------------------------------------------
                          Meeting                                                  Date(s)
----------------------------------------------------------------------------------------------------------------
BL/CS R&D Surgery Subcommittee.............................  November 12, 2019.
BL/CS R&D Pulmonary Medicine Subcommittee..................  November 13, 2019.
BL/CS R&D Infectious Diseases-B Subcommittee...............  November 14, 2019.
BL/CS R&D Oncology-A/D Subcommittee........................  November 14, 2019.
BL/CS R&D Hematology Subcommittee..........................  November 15, 2019.
BL/CS R&D Oncology-C Subcommittee..........................  November 15, 2019.
BL/CS R&D Cellular & Molecular Medicine Subcommittee.......  November 18, 2019.
BL/CS R&D Oncology-B/E Subcommittee........................  November 18, 2019.
BL/CS R&D Immunology & Dermatology-A Subcommittee..........  November 20, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-C              November 20, 2019.
 Subcommittee.
BL/CS R&D Cardiovascular Studies-A Subcommittee............  November 21, 2019.
BL/CS R&D Endocrinology-A Subcommittee.....................  November 21, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-P............  November 21, 2019.
BL/CS R&D Neurobiology-C Subcommittee......................  November 21, 2019.
BL/CS R&D Neurobiology-E Subcommittee......................  November 22, 2019.

[[Page 55232]]

 
BL/CS R&D Endocrinology-B Subcommittee.....................  November 25, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-A              December 3, 2019.
 Subcommittee.
BL/CS R&D Nephrology Subcommittee..........................  December 3, 2019.
BL/CS R&D Neurobiology-B Subcommittee......................  December 3, 2019.
BL/CS R&D Infectious Diseases-A Subcommittee...............  December 4, 2019.
BL/CS R&D Neurobiology-F Subcommittee......................  December 4, 2019.
BL/CS R&D Cardiovascular Studies-B Subcommittee............  December 5, 2019.
BL/CS R&D Gastroenterology Subcommittee....................  December 5, 2019.
BL/CS R&D Neurobiology-P Subcommittee......................  December 5, 2019.
BL/CS R&D Neurobiology-A Subcommittee......................  December 6, 2019.
BL/CS R&D Neurobiology-D Subcommittee......................  December 6, 2019.
BL/CS R&D Gulf War Research Subcommittee...................  December 6, 2019.
BL/CS R&D Eligibility Subcommittee.........................  January 17, 2020.
----------------------------------------------------------------------------------------------------------------

    The purpose of the subcommittees is to provide advice on the 
scientific quality, budget, safety and mission relevance of 
investigator-initiated research proposals submitted for VA merit review 
evaluation. Proposals submitted for review include various medical 
specialties within the general areas of biomedical, behavioral and 
clinical science research.
    These subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
proposals, which involve reference to staff and consultant critiques of 
research proposals. Discussions will deal with scientific merit of each 
proposal and qualifications of personnel conducting the studies, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy. Additionally, premature disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals. As provided by 
subsection 10(d) of Public Law 92-463, as amended by Public Law 94-409, 
closing the subcommittee meetings is in accordance with Title 5 U.S.C. 
552b(c)(6) and (9)(B).
    Those who would like to obtain a copy of the minutes from the 
closed subcommittee meetings and rosters of the subcommittee members 
should contact Holly Krull, Ph.D., Manager, Merit Review Program 
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, 
Washington, DC 20420, at (202) 632-8522 or email at [email protected].

    Dated: October 8, 2019.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-22378 Filed 10-11-19; 8:45 am]
BILLING CODE 8320-01-P